Clinical Trial Update: Development of Visual Function Evaluation Method

View source ↗

Summary

This clinical trial update reports the completion of a study by Astellas Pharma on developing a visual function evaluation method for Retinitis Pigmentosa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Retinitis Pigmentosa | Status: COMPLETED